EuropaBio Newsletter 2009 - Biotechnology in Europe

26 Jan - 1 Feb 2010

Previous edition January, 19-25
Upcoming Events 1 - 2 February, Biosquare 2010, Geneva, Switzerland 24 - 26 February, European Convention on Global Sustainable Bioenergy, Delft, The Netherlands 3 - 5 March, EMBL Workshop on Visualizing Biological Data (VizBi), Heidelberg, Germany
Suscribe to our RSS feed
Follow us
Twitter	Facebook
Watch our videos on Youtube
Join us on Facebook
EuropaBio Weekly subscribe EuropaBio Weekly unsubscribe EuropaBio Weekly
EuropaBio Avenue de l'Armée 6 B-1040 Brussels, Belgium Tel: +32 2 735 03 13 Fax: +32 2 735 49 60 http://www.europabio.org

If you can not read this newsletter, click here

	Headlines
	Event - Biosquare 2010, Geneva, Switzerland - 1 & 2 February 2010.
	Event - 2^nd Annual European Public Relations and Communications Summit 29-30 March 2010, Berlin Germany. 5% Discount for our readers when you register here quoting this code: “P236EuropaBio”.
	Event - 2^nd Annual Digital Pharma Europe Summit, 29-30 March 2010, Berlin Germany. 5% discount for our readers when you register here quoting this code: “P236EuropaBio”.
	Greens embrace enzymes in climate change fight Industrial biotechnology is gaining supporters among environmentalists as a way to make significant cuts in greenhouse-gas emissions and eventually move to a society free from fossil fuels.
	Green Biotech (top)
	Biotechnology is Key to Food Security in Africa. Africa missed on the “Green Revolution” that drove Asia; the West and the larger America out of food insecurity five decades ago, but Agricultural Scientists in Kenya say, it should not miss out on the “Gene Revolution” seen to transform food production policy in the continent.
	Lack of GMOs costs lives, claims leading scientist Many human lives have been lost due to the reluctance of some countries to accept genetically modified crops, former government chief scientific adviser, Sir David King has claimed.
	Red Biotech (top)
	GSK backs open innovation strategy on treatments for neglected tropical diseases GlaxoSmithKline is to establish an ‘Open Lab’ with $8 million funding to carry out research into neglected tropical diseases, as part of a series of measures to change the company’s approach to developing treatments for them.
	Biotech drug database goes public Biochemists focused on drug discovery take note: the UK's Wellcome Trust has announced that an online database of drugs that it bought in 2008 from a private biotech company is now officially launched as a free, open-access concern.
	White Biotech (top)
	French government launches bio-based waste bag plan France's ecology minister, Chantal Jouanno, has launched a framework agreement to promote bio-based, compostable plastic waste bags in the country.
	SusChem Innovation Project wins INNOVA funding SusChem’s first pan European Innovation project - BIOCHEM - has been selected for funding by the European Commission under its INNOVAscheme. INNOVA is part of the Competitiveness and Innovation Programme (CIP) managed (during 2009) by DG Enterprise. The proposed total cost of the BIOCHEM project is €4.5M including a significant EU contribution. The project will hold its kick-off meeting on 5 February 2010.
	Other (top)
	Extraordinary Measures, a movie directed by Tom Vaughan Rare diseases and drug discovery don't usually make for Hollywood blockbusters. But this month a film about a genetic affliction that strikes fewer than 10,000 people worldwide hits movie screens, and it has some serious star power behind it.